Hims & Hers Health：諾和諾德的訴訟是一種「公然的攻擊」

老虎資訊綜合

02/09

周一，Hims & Hers Health Inc. 發表聲明：諾和諾德的訴訟是對數百萬依賴複方藥獲得個性化治療的美國民衆公然的攻擊，大型製藥企業再次將美國司法體系武器化以限制消費者選擇。

聲明稱，Hims & Hers Health長期為數百萬美國人提供安全獲取個性化醫療服務的渠道，將繼續奮戰以保障選擇權、可負擔性及可及性。

諾和諾德當天早些時候宣佈，已就Hims & Hers Health在美國市場銷售的複方司美格魯肽產品侵犯專利提起訴訟。

截至發稿，Hims & Hers Health的盤前跌幅擴大至超22%。

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1168115277"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1168115277\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1168115277?lang=zh_TW&edition=fundamental","thumbnail":"https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955","is_english":false,"pubTime":"2026-02-09 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1168115277","market":"us","top_or_hot":-1,"title":"Hims & Hers Health：諾和諾德的訴訟是一種「公然的攻擊」","media":"老虎資訊綜合","content":"<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 發表聲明： <a href=\"https://laohu8.com/S/NVO\">諾和諾德</a> 的訴訟是對數百萬依賴複方藥獲得個性化治療的美國民衆公然的攻擊，大型製藥企業再次將美國司法體系武器化以限制消費者選擇。</p><p>聲明稱，Hims &amp; Hers Health長期為數百萬美國人提供安全獲取個性化醫療服務的渠道，將繼續奮戰以保障選擇權、可負擔性及可及性。</p><p>諾和諾德當天早些時候宣佈，已就Hims &amp; Hers Health在美國市場銷售的複方司美格魯肽產品侵犯專利提起訴訟。</p><p>截至發稿，Hims &amp; Hers Health的盤前跌幅擴大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health：諾和諾德的訴訟是一種「公然的攻擊」</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health：諾和諾德的訴訟是一種「公然的攻擊」\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎資訊綜合 </p>\n<p class=\"h-time smaller\">2026-02-09 21:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><head></head><body><p>周一，<a href=\"https://laohu8.com/S/HIMS\">Hims &amp; Hers Health Inc.</a> 發表聲明： <a href=\"https://laohu8.com/S/NVO\">諾和諾德</a> 的訴訟是對數百萬依賴複方藥獲得個性化治療的美國民衆公然的攻擊，大型製藥企業再次將美國司法體系武器化以限制消費者選擇。</p><p>聲明稱，Hims &amp; Hers Health長期為數百萬美國人提供安全獲取個性化醫療服務的渠道，將繼續奮戰以保障選擇權、可負擔性及可及性。</p><p>諾和諾德當天早些時候宣佈，已就Hims &amp; Hers Health在美國市場銷售的複方司美格魯肽產品侵犯專利提起訴訟。</p><p>截至發稿，Hims &amp; Hers Health的盤前跌幅擴大至超22%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1d2ef067a4fc93d89080158e0154607b\" tg-width=\"1161\" tg-height=\"417\"/></p><p></p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HMYY","symbol_name":"GraniteShares YieldBoost HIMS ETF","start_time":0,"source_url":"","article_id":"1168115277","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/93eef2d936f05d4726617f16ec785955"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1168115277","pubTimestamp":1770645283,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎資訊綜合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"將繼續奮戰以保障選擇權、可負擔性及可及性。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"HMYY":"GraniteShares YieldBoost HIMS ETF","HIMS":"Hims & Hers Health Inc.","HIMZ":"DEFIANCE DAILY TARGET 2X LONG HIMS ETF","NVO":"诺和诺德","HIMY":"Defiance Leveraged Long + Income HIMS ETF"},"translate_title":"Hims & Hers Health: Novo Nordisk's lawsuit is a'blatant attack '","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HMYY":1,"HIMY":1,"HIMS":2,"NVO":2,"HIMZ":1},"content_text":"周一，Hims & Hers Health Inc. 發表聲明： 諾和諾德 的訴訟是對數百萬依賴複方藥獲得個性化治療的美國民眾公然的攻擊，大型製藥企業再次將美國司法體系武器化以限制消費者選擇。聲明稱，Hims & Hers Health長期為數百萬美國人提供安全獲取個性化醫療服務的渠道，將繼續奮戰以保障選擇權、可負擔性及可及性。諾和諾德當天早些時候宣佈，已就Hims & Hers Health在美國市場銷售的複方司美格魯肽產品侵犯專利提起訴訟。截至發稿，Hims & Hers Health的盤前跌幅擴大至超22%。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}